GMPs, QA & QC

2012’s predictions: How did we do?

2012’s predictions: How did we do?

By Stephen DANIELLS

In January, NutraIngredients-USA raised its head above the parapet and made some predictions for 2012. As the year draws to a close, we look back on what did and didn’t come to pass.

The FDA has developed and 'quick and easy' screening procedure for adulterants

FDA develops rapid screening for adulterants in weight loss products

By Stephen DANIELLS

Scientists from the US Food and Drug Administration (FDA) have developed a rapid procedure to screen for adulterants in weight-loss products, which could benefit the industry by impacting the ‘rate at which these adulterated products find their way to...

FDA: Inflammation and diabetes raising red flags for tainted products

FDA: Inflammation and diabetes raising red flags for tainted products

By Stephen Daniells in Laguna Beach

Concerns over tainted dietary supplements are extending to products promoted for pain/inflammation and diabetes, beyond the ‘classic’ sectors of erectile dysfunction, weight loss and bodybuilding, said the new head of CFSAN at FDA.

Good 483 responses can squelch warning letters

Good 483 responses can squelch warning letters

By Hank Schultz

Good responses to 483 can avoid a warning letter.  Including in those responses key elements of organization and documentation can improve the chances for success, an experts say.

Olympic Games throw light on supplement contamination

Industry hopes Olympics will torch supplement contamination concerns

By Shane STARLING

The Olympic Games have in the past brought the food supplements industry to the edge of its collective seat – but not necessarily in fevered anticipation of the world-class sporting fare on offer as anti-doping scrutiny has raised contamination issues.

With the Olympic Games approaching, NAI is predicting growing interest in its patented beta-alanine ingredient CarnoSyn

NAI posts 30% surge in sales in Q3, 2012

By Elaine Watson

California-based nutritional supplement contract manufacturer Natural Alternatives International (NAI) has posted a 30.3% rise in net sales to $17.4m in the three months to March 31, 2012.

FDA: We’re not enforcing NDI draft guidance; GMPs are the biggest issue

Dispatches from AHPA's Botanical Congress

FDA: We’re not enforcing NDI draft guidance; GMPs are the biggest issue

By Stephen Daniells

The Food & Drug Administration is not preparing to enforce its controversial draft guidance on new dietary ingredients (NDIs), but companies can expect more inspections, more injunctions, and more product seizures related to current good manufacturing...

Follow us

Products

View more

Webinars